Skip to main content
. 2020 Jun 29;12(7):1925. doi: 10.3390/nu12071925
A
AdoCbl–5′Adenosyl cobalamin Adenosyl cobalamin
AGPAT3 Acylglycerol−3-phosphate O-acyltransferases 3
B
BMI Body mass index
C
CAD Coronary artery disease
CHD Coronary heart disease
CKD Chronic kidney disease
CpG 5′cytosine-phosphate-guanine-3′
CPT1α Carnitine palmitoyl transferase I alpha
CVD Cardiovascular diseases
D
DAG Diacylglycerol
DGAT 1&2 Diacylglycerol acyltransferase 1&2
DKA Diabetic keto acidosis
DM Diabetes mellitus
DMB 5, 6-dimethylbenzimidazole
DNMTs DNA methyl transferases
E
ESRD End-stage renal disease
ESR1 Estrogen receptor 1
ETC Electron transport chain
F
FAO Fatty acid oxidation
FAS Fatty acid synthase
FFA Free fatty acids
G
GDM Gestational diabetes mellitus
GIT Gastrointestinal tract
GPAT Glycerol-3-phosphate acyltransferase
H
HATS Histone acetyltransferases
HC Haptocorrin
HDACs Histone deacetylases
HDL-C High-density lipoprotein cholesterol
HFD High fat diet
tHcy total homocysteine
HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase
HMGCS 3-hydroxy-3-methylglutaryl-CoA synthase
HoloTC Holotranscobalamin
HOMA-IR Homeostasis model of insulin resistance
I
IDF International Diabetes Federation
IF Intrinsic factor
IR Insulin resistance
L
LCFAs Long-chain fatty acids
LDL-C Low-density lipoprotein cholesterol
LDLR Low-density lipoprotein receptor
LXR-α Liver X receptor alpha
M
MCM Methyl malonyl CoA mutase
MeCbl Methyl-cobalamin
MetS Metabolic syndrome
MI Myocardial infarction
MMA Methyl malonic acid
MS Methionine synthase
MP Methylation potential
miRNAs MicroRNAs
N
NAFLD Non-alcoholic fatty liver disease
NASH Non-alcoholic steatohepatitis
P
PPAR-γ Peroxisome proliferator-activated receptor gamma
S
SAM S-adenosyl methionine
SAH S- adenosyl homocysteine
ScAT Subcutaneous adipose tissues
SREBF1&2 Sterol regulatory element binding protein 1 and 2
stRNAs Small temporal RNAs
T
TCA Tricarboxylic acid
TC Transcobalamin
TCR or TCbIR Transcobalamin receptor
T2D Type 2 diabetes mellitus
TG Triglyceride/Triacylglycerol
TNFα Tumor necrosis factor-alpha
V
VLDL Very low-density lipoprotein
W
WHO World Health Organization